Literature DB >> 2516398

Endomyocardial biopsy in children with Kawasaki disease.

S Yonesaka, T Nakada, Y Sunagawa, K Tomimoto, S Naka, T Takahashi, T Matubara, I Sekigami.   

Abstract

To study the histopathology of the myocardium in Kawasaki Disease (KD) with various coronary angiographic findings, right endomyocardial biopsy specimens were evaluated on 20 boys and 16 girls with this disorder. KD with coronary artery lesions (CAL) showed various histopathological abnormalities, such as myocellular hypertrophy in 44%, degeneration in 61%, interstitial fibrosis in 44% and endomyocardial changes in 22%. KD without CAL revealed myocellular hypertrophy in 44%, degeneration in 50%, disarray in 28% and interstitial fibrosis in 6%. As in patients with long-standing KD, more than three years after onset, myocardial changes such as myocellular hypertrophy, disarray and interstitial fibrosis persisted, it is suggested that cardiomyopathy may develop in some patients with KD.

Entities:  

Mesh:

Year:  1989        PMID: 2516398     DOI: 10.1111/j.1442-200x.1989.tb01384.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  12 in total

Review 1.  Kawasaki Disease update.

Authors:  Jane C Burns
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

2.  Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).

Authors:  Adriana H Tremoulet; Sonia Jain; Susan Kim; Jane Newburger; Moshe Arditi; Alessandra Franco; Brookie Best; Jane C Burns
Journal:  Contemp Clin Trials       Date:  2016-04-11       Impact factor: 2.226

3.  Serial evaluation of myocardial function using the myocardial performance index in Kawasaki disease.

Authors:  Eun Song Song; Somy Yoon; Joo Hyun Cho; Eun Mi Yang; Hwa Jin Cho; Young Youn Choi; Jae Sook Ma; Gwang Hyeon Eom; Young Kuk Cho
Journal:  World J Pediatr       Date:  2018-03-12       Impact factor: 2.764

4.  Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood.

Authors:  Chisato Shimizu; Alka Sood; Hubert D Lau; Toshiaki Oharaseki; Kei Takahashi; Henry F Krous; Steven Campman; Jane C Burns
Journal:  Cardiovasc Pathol       Date:  2015-02-24       Impact factor: 2.185

5.  Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis.

Authors:  Harry H Matundan; Jon Sin; Magali Noval Rivas; Michael C Fishbein; Thomas J Lehman; Shuang Chen; Roberta A Gottlieb; Timothy R Crother; Masanori Abe; Moshe Arditi
Journal:  JCI Insight       Date:  2019-02-07

6.  Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C.

Authors:  Yanfang P Zhu; Isaac Shamie; Jamie C Lee; Cameron J Nowell; Weiqi Peng; Shiela Angulo; Linh Nn Le; Yushan Liu; Huilai Miao; Hainan Xiong; Cathleen J Pena; Elizabeth Moreno; Eric Griffis; Stephanie G Labou; Alessandra Franco; Lori Broderick; Hal M Hoffman; Chisato Shimizu; Nathan E Lewis; John T Kanegaye; Adriana H Tremoulet; Jane C Burns; Ben A Croker
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

7.  QT interval dispersion in North Indian children with Kawasaki disease without overt coronary artery abnormalities.

Authors:  Sunil J Ghelani; Surjit Singh; Rohit Manojkumar
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

8.  Evaluation of myocardial function by pulsed tissue Doppler in Kawasaki disease.

Authors:  Hamid Amoozgar; Somaieh Mehdizadeh; Gholamhossein Ajami; Soheila Alyasin; Mohammad Borzoee; Saeed Abtahi; Siros Cheriki
Journal:  Pediatr Cardiol       Date:  2009-06-16       Impact factor: 1.655

Review 9.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

10.  Differential expression of miR-145 in children with Kawasaki disease.

Authors:  Chisato Shimizu; Jihoon Kim; Petra Stepanowsky; Christine Trinh; Hubert D Lau; Johnny C Akers; Clark Chen; John T Kanegaye; Adriana Tremoulet; Lucila Ohno-Machado; Jane C Burns
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.